Shanghai Allist Pharmaceuticals Co., Ltd.
688578
Rangering i aksjer
#3127
Established in 2004, Shanghai Allist Pharmaceuticals Co., Ltd. is a Chinese... Established in 2004, Shanghai Allist Pharmaceuticals Co., Ltd. is a Chinese enterprise dedicated to the innovation and development of medicinal products. Headquartered in Shanghai, the company focuses its efforts on creating therapeutic agents specifically for the treatment of various tumor and cancer-related conditions.
Aksjekurs
$12.65
Markedsverdi
$5.69B
Endring (1 dag)
-0.05%
Endring (1 år)
-14.35%
Land
CN
Handel Shanghai Allist Pharmaceuticals Co., Ltd. (688578)
Kategori
Healthcare
P/B-forhold for Shanghai Allist Pharmaceuticals Co., Ltd. (688578)
P/B-forhold per October 2026 TTM: 4.49
Ifølge Shanghai Allist Pharmaceuticals Co., Ltd. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 4.49. Ved slutten av 2024 hadde selskapet et P/B-forhold på 5.10.
P/B-historikk for Shanghai Allist Pharmaceuticals Co., Ltd. fra 2017 til 2026
P/B-forhold ved hvert års slutt
| År | P/B-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 4.49 | -32.02% |
| 2025 | 6.61 | 29.71% |
| 2024 | 5.10 | 8.19% |
| 2023 | 4.71 | 69.56% |
| 2022 | 2.78 | -40.11% |
| 2021 | 4.64 | 26.86% |
| 2020 | 3.66 | -68.90% |
| 2019 | 11.76 | 0.00% |
| 2018 | 0.00 | 0.00% |
| 2017 | 0.00 | 0.00% |
P/B-forhold for lignende selskaper eller konkurrenter
| Selskap | P/B-forhold | Forskjell i P/B-forhold | Land |
|---|---|---|---|
| 6.251 | 39.11% |
US
|
|
| 13.6307 | 203.34% |
US
|
|
| 4.4521 | -0.92% |
AU
|
|
| 3.2932 | -26.71% |
BE
|
|
| 6.3632 | 41.61% |
NL
|
